Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-26T18:26:10.009Z Has data issue: false hasContentIssue false

Neurobiological and Clinical Predictors of Impulsivity in Bulimia Nervosa [P02-69]

Published online by Cambridge University Press:  16 April 2020

F.J. Vaz Leal
Affiliation:
Psychiatry, Extremadura University, Badajoz, Spain
L. Rodríguez Santos
Affiliation:
Psychiatry, Extremadura University, Badajoz, Spain
M.I. Ramos Fuentes
Affiliation:
Psychiatry, Extremadura University, Badajoz, Spain
M.J. Cardoso Moreno
Affiliation:
Psychiatry, Extremadura University, Badajoz, Spain
N. Fernández Sánchez
Affiliation:
Psychiatry, Extremadura University, Badajoz, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

The main aim of this study was to analyze the association between a set of neurobiological/clinical factors and impulsivity in patients suffering from bulimia nervosa, as well as the capability of this factors to predict the severity of impulsivity.

Methods:

The Impulsive Behaviors Scale (IBS), the Diagnostic Interview for Bordeline Patients - Revised (DIB-R), the Beck Depression Inventory (BDI), the Millon Multiaxial Clinical Inventory (MMCI-II) and the Family Environment Scale (FES) were applied to 70 female patients with DSM-IV BN (purging subtype). Twenty-four hour urinary excretion of norepinephrine (NE), 3-methoxy-4-hydroxyphenylglycol (MHPG), serotonin (5-HT), 5-hydroxi-indol-acetic acid (5-HIAA), dopamine (DA), homovallinic acid (HVA), and morning serum cortisol levels before and after the administration of 1 mg of dexamethasone were determined.

Results:

Impulsivity was associated to lower levels of urinary 5-HT and 5-HIAA, borderline features, and lower family expressed emotion.

Conclusions:

The consideration of impulsivity as a core clinical feature in patients with bulimia nervosa could lead us to identify clinical subtypes of patients, with specific clinical profiles and specific treatment needs.

Type
P02-69
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.